SER Stock Analysis: Buy, Sell, or Hold?
SER - Serina Therapeutics, Inc.
$2.18
0.05 (2.35%)
▲
5d:
+6.34%
30d:
+10.1%
90d:
+6.34%
BUY
MODERATE Confidence
Analysis Updated: Jul 20, 2026 12:00 AM ET
Earnings: Aug 10, 2026
19d
Get Alerted When SER Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: SER shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: SER shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: SER is currently trading at $2.18, which is considered extended relative to its 30-day fair value range of $1.87 to $2.10.
Technical Outlook: Technically, SER is in a strong downtrend. Immediate support is located at $1.91, while resistance sits at $2.28.
Market Sentiment: SER has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $9.50 (+335.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SER is in a strong downtrend. Immediate support is located at $1.91, while resistance sits at $2.28.
Market Sentiment: SER has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $9.50 (+335.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.87 -
$2.10
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 335.8% below Wall St target ($9.50)
Trading Range Analysis
30-Day Trading Range
$1.87 -
$2.10
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.91
Resistance Level
$2.28
Current Trend
Strong Downtrend
Technical data as of
Jul 20, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.08
Wall Street Target
$9.50
(+335.8%)
Revenue Growth (YoY)
154.9%
Earnings Growth (YoY)
-43.5%
Share & Embed Analysis
Last updated: July 21, 2026 5:25 AM ET
Data refreshes hourly during market hours. Next update: 6:25 AM
Data refreshes hourly during market hours. Next update: 6:25 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SER showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$415 | 61 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 62 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$93 | 50 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 54 HOLD |
